30 results
Thumbnail

D2.480 - Features of the molecular sensitization profile in children with autism spectrum disorder

Thumbnail

D2.485 - Comprehensive Understanding of the Characteristics of Pediatric Pollen Allergy Patients

Thumbnail

D2.486 - Levels of house dust mite in dust settlements are associated with risk for allergic rhinitis in children

Thumbnail

D2.489 - B-Cell Subset Reconstitution After Rituximab-Containing Chemotherapy in Children and Adolescents With Non-Hodgkin Lymphoma: A Single-Center Experience

Thumbnail

D2.478 - HEREDITORY ANGIOEDEMA - A case report

Thumbnail

D2.477 - Nationwide Survey of Healthcare Transition from Paediatric to Adult Services for Allergic Diseases in Japan

Thumbnail

D2.479 - The bullous pemphigoid in a baby

Thumbnail

D2.481 - Severe obstructive syndrome in children with bronchopulmonary malformations

Thumbnail

D2.482 - Neuroendocrine Cell Hyperplasia of Infancy (NEHI): Report of 7 Cases

Thumbnail

D2.483 - Outdoor Activity and Screen Time at Age 3 years and Allergic Symptoms at Age 6 years: A Nationwide Birth Cohort Study (JECS)

Thumbnail

D2.487 - Avoiding Unnecessary Food Avoidance: Outcomes of Infants with Localised Reactions During Weaning

Thumbnail

D2.488 - Functional confirmation of exercise-induced bronchoconstriction in children: A three-year retrospective study

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort

Thumbnail

D3.442 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Open-Label Extension Cohort